Each one of our 150+ scientific and regulatory consultants
has an average of more than 15 years of industry and FDA experience and training. Our regulatory experts
have had successful interactions with global regulatory agencies and have worked with every review division of the FDA. Cardinal Health has provided support for more than 100 New Drug Application (NDA), Biologic License Application (BLA) and Abbreviated New Drug Application (ANDA) approvals and has provided drug development services for new drugs in all major therapeutic areas. We leverage the extensive knowledge and expertise gained from our experiences with global clients to continue improving upon our services and internal processes.